This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jenks, P. J.
Right arrow Articles by Labigne, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jenks, P. J.
Right arrow Articles by Labigne, A.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, October 2000, p. 2623-2629, Vol. 44, No. 10
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Evaluation of Nitrofurantoin Combination Therapy of Metronidazole-Sensitive and -Resistant Helicobacter pylori Infections in Mice

Peter J. Jenks,1,2,* Richard L. Ferrero,1 Jacques Tankovic,3 Jean-Michel Thiberge,1 and Agnès Labigne1

Unité de Pathogénie Bactérienne des Muqueuses, Institut Pasteur, 75724 Paris Cedex 15,1 and Service de Bactériologie-Virologie, Hôpital Henri Mondor, Creteil,3 France, and Department of Medical Microbiology, Royal Free and University College Medical School, London, United Kingdom2

Received 7 February 2000/Returned for modification 1 June 2000/Accepted 27 June 2000

The main objectives of this study were to determine whether the nitroreductase enzyme encoded by the rdxA gene of Helicobacter pylori was responsible for reductive activation of nitrofurantoin and whether a triple-therapy regimen with nitrofurantoin was able to eradicate metronidazole-sensitive and -resistant H. pylori infections from mice. The susceptibilities to nitrofurantoin of parent and isogenic rdxA mutant strains (three pairs), as well as a series of matched metronidazole-sensitive and -resistant strains isolated from mice (30) and patients (20), were assessed by agar dilution determination of the MIC. Groups of mice colonized with the metronidazole-sensitive H. pylori SS1 strain or a metronidazole-resistant rdxA SS1 mutant were treated with either metronidazole or nitrofurantoin as part of a triple-therapy regimen. One month after the completion of treatment the mice were sacrificed and their stomachs were cultured for H. pylori. The nitrofurantoin MICs for all strains tested were between 0.5 and 4.0 µg/ml. There was no significant difference between the susceptibility to nitrofurantoin of the parental strains and those of respective rdxA mutants or between those of matched metronidazole-sensitive and -resistant H. pylori isolates. The regimen with metronidazole eradicated infection from all eight SS1-infected mice and from one of eight mice inoculated with the rdxA mutant (P <=  0.001). The regimen with nitrofurantoin failed to eradicate infection from any of the six SS1-infected mice (P <=  0.001) and cleared infection from one of seven mice inoculated with the rdxA mutant. These results demonstrate that, despite the good in vitro activity of nitrofurantoin against H. pylori and the lack of cross-resistance between metronidazole and nitrofurantoin, eradication regimens involving nitrofurantoin are unable to eradicate either metronidazole-sensitive or -resistant H. pylori infections from mice.

* Corresponding author. Mailing address: Department of Medical Microbiology, Royal Free and University College Medical School, Royal Free Campus, Rowland Hill St., London NW3 2PF, United Kingdom. Phone: 44-20-77940500, ext. 4111. Fax: 44-20-77940433. E-mail: pjenks2{at}hotmail.com.

Antimicrobial Agents and Chemotherapy, October 2000, p. 2623-2629, Vol. 44, No. 10
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Paraschos, S., Magiatis, P., Mitakou, S., Petraki, K., Kalliaropoulos, A., Maragkoudakis, P., Mentis, A., Sgouras, D., Skaltsounis, A.-L. (2007). In Vitro and In Vivo Activities of Chios Mastic Gum Extracts and Constituents against Helicobacter pylori. Antimicrob. Agents Chemother. 51: 551-559 [Abstract] [Full Text]  
  • van Zanten, S. J. O. V., Kolesnikow, T., Leung, V., O'Rourke, J. L., Lee, A. (2003). Gastric Transitional Zones, Areas where Helicobacter Treatment Fails: Results of a Treatment Trial Using the Sydney Strain Mouse Model. Antimicrob. Agents Chemother. 47: 2249-2255 [Abstract] [Full Text]  
  • Loughlin, M. F., Barnard, F. M., Jenkins, D., Sharples, G. J., Jenks, P. J. (2003). Helicobacter pylori Mutants Defective in RuvC Holliday Junction Resolvase Display Reduced Macrophage Survival and Spontaneous Clearance from the Murine Gastric Mucosa. Infect. Immun. 71: 2022-2031 [Abstract] [Full Text]  
  • Loughlin, M. F., Ala'Aldeen, D. A., Jenks, P. J. (2003). Monotherapy with mastic does not eradicate Helicobacter pylori infection from mice. J Antimicrob Chemother 51: 367-371 [Abstract] [Full Text]  
  • Sisson, G., Goodwin, A., Raudonikiene, A., Hughes, N. J., Mukhopadhyay, A. K., Berg, D. E., Hoffman, P. S. (2002). Enzymes Associated with Reductive Activation and Action of Nitazoxanide, Nitrofurans, and Metronidazole in Helicobacter pylori. Antimicrob. Agents Chemother. 46: 2116-2123 [Abstract] [Full Text]  
  • Latham, S. R., Labigne, A., Jenks, P. J. (2002). Production of the RdxA protein in metronidazole-susceptible and -resistant isolates of Helicobacter pylori cultured from treated mice. J Antimicrob Chemother 49: 675-678 [Abstract] [Full Text]  
  • Latham, S. R., Owen, R. J., Elviss, N. C., Labigne, A., Jenks, P. J. (2001). Differentiation of Metronidazole-Sensitive and -Resistant Clinical Isolates of Helicobacter pylori by Immunoblotting with Antisera to the RdxA Protein. J. Clin. Microbiol. 39: 3052-3055 [Abstract] [Full Text]  
  • Touati, E., Hofnung, M., Thiberge, J.-M., Michel, V., Labigne, A., Jenks, P. J. (2000). Short-term infection with Helicobacter pylori and 1 week exposure to metronidazole does not enhance gastric mutation frequency in transgenic mice. J Antimicrob Chemother 46: 987-992 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»